Steven D. Weitman

Health Technology

Consumer Services

Profile

Steven D.
Weitman served as the Chief Medical Officer & Senior Vice President at ILEX Oncology, Inc. and as an Associate Professor at The Medical College of Wisconsin, Inc. and the University of Texas Health Center.
He also served as the Chief Medical Officer at Unibioscreen SA. Weitman holds a doctorate degree from The Medical College of Wisconsin, Inc.

Former positions of Steven D. Weitman

Companies	Position	End
Unibioscreen SA Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline.	Chief Tech/Sci/R&D Officer	09/05/2011
ILEX Oncology, Inc. ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX.	Corporate Officer/Principal	27/03/2006
University of Texas Health Center	Corporate Officer/Principal	-
The Medical College of Wisconsin, Inc.	Corporate Officer/Principal	-

See the detail of Steven D. Weitman's experience

Training of Steven D. Weitman

The Medical College of Wisconsin, Inc.

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies